RVPH icon

Reviva Pharmaceuticals

21 hedge funds and large institutions have $39.6M invested in Reviva Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
Holders Change %
0%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
MSU
1
Mizuho Securities USA
New York
$6.21M +$286K +27,585 +5%
KIM
2
Karpus Investment Management
New York
$3.9M +$226K +21,850 +6%
OAM
3
Oxford Asset Management
United Kingdom
$3.83M
Bank of America
4
Bank of America
North Carolina
$3.43M
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$3.33M
PC
6
Periscope Capital
Ontario, Canada
$3.02M -$2.07K -200 -0.1%
SCM
7
Shaolin Capital Management
Florida
$2.5M
BFM
8
Boothbay Fund Management
New York
$2.02M -$673K -65,021 -25%
GCIA
9
Gabelli & Co Investment Advisers
New York
$2.01M
CIM
10
Cowen Investment Management
New York
$1.81M +$1.81M +175,000 New
Goldman Sachs
11
Goldman Sachs
New York
$1.55M
GF
12
Gabelli Funds
New York
$1.22M
CAC
13
Cowen and Company
New York
$1.12M +$1.12M +108,121 New
Walleye Trading
14
Walleye Trading
New York
$1.08M -$98.3K -9,500 -8%
WAM
15
Weiss Asset Management
Massachusetts
$974K
BI
16
Bulldog Investors
New Jersey
$562K
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$518K
BCM
18
Basso Capital Management
Connecticut
$259K -$1.94K -188 -0.7%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$238K +$141K +13,660 +146%
UBS Group
20
UBS Group
Switzerland
$24K +$12.8K +1,247 +113%
PAM
21
Panagora Asset Management
Massachusetts
$14K -$1.19M -114,987 -99%
HIM
22
HGC Investment Management
Ontario, Canada
-$3K -200 Closed